BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35150042)

  • 1. CTLA-4 polymorphism contributes to the genetic susceptibility of epithelial ovarian cancer.
    Chen J; Kang S; Wu J; Zhao J; Si W; Sun H; Li Y
    J Obstet Gynaecol Res; 2022 May; 48(5):1240-1247. PubMed ID: 35150042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in
    Si W; Kang S; Sun H; Chen J; Cao S; Li Y
    Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
    Xiao W; Zhang Q; Deng XZ; Jiang LF; Zhu DY; Pei JP; Ge CY; Li BJ; Wang CJ; Zhang JH; Zhou ZX; Ding WL; Xu XD; Yue M
    Infect Genet Evol; 2015 Aug; 34():52-60. PubMed ID: 26079279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
    Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
    DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
    Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
    J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms and Circulating Plasma Protein Levels of Immune Checkpoints (CTLA-4 and PD-1) Are Associated With Posner-Schlossman Syndrome in Southern Chinese.
    Huang X; Liu X; Ye Y; Zhang T; Mei S; Zhu T; Peng S; Cai J; Yan Z; Zeng K; Nie D; Sun L; Hou X; Zhao J
    Front Immunol; 2021; 12():607966. PubMed ID: 33717091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of CD152 polymorphisms on cervical cancer susceptibility.
    Cao S; Zheng L
    Pathol Res Pract; 2020 Aug; 216(8):152918. PubMed ID: 32616425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
    Wang JJ; Wang ZB; Tan TC
    Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
    Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
    Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Thyroid Cancer and CTLA-4 Gene Polymorphisms.
    Sun L; Niu T; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):31-36. PubMed ID: 37329551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T-lymphocyte Antigen-4 (
    VAN Nguyen S; Shamoun L; Landerholm K; Andersson RE; Wagsater D; Dimberg J
    In Vivo; 2021; 35(2):969-975. PubMed ID: 33622891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
    Xiong YH; He L; Fei J
    Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Liang J; Li Y; Wang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population.
    Liu J; Tang W; Lin W; Wang Y; Chen Y; Wang J; Liu M; Xu W; Lin J; Zhang L
    DNA Cell Biol; 2019 May; 38(5):443-448. PubMed ID: 30888206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between SNPs of Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death 1 (PD-1)and the susceptibility to chronic Hepatitis C infection in virus C-infected patients.
    Ali ESG; Bassyouni RH; Abdelaleem OO; Hassan EA; Gaber SN
    Virus Res; 2022 Mar; 310():198684. PubMed ID: 35063794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.